Thursday, September 10, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Allison Hamner, PharmD, BCPS
a Clinical Pharmacy Specialist in Bone Marrow Transplant and Cellular Therapy
The Gayle and Tom Benson Cancer Center, Ochsner Medical Center
Published Articles (1)
Managing Bispecific T-Cell Engager Toxicity: CRS and ICANs in Practice
August 4, 2026
Bispecific T-cell engagers (BiTEs) offer major efficacy in hematologic malignancies, but their signature toxicities—cytokine release syndrome (CRS) and ICANS—require real-time vigilance and management similar to CAR T-cell therapy.